Pharmaceutical Technology

JULY 28, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? July 28, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook HRS-9821 aligns with GSK’s goal to address a broad spectrum of COPD patients. Credit: OleksSH / Shutterstock.com.

Packaging

Pharmaceutical Technology

AUGUST 5, 2025

Robert Barrie August 5, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook In 2023, a record 85,000 cases of the disease were reported in England — three times higher than in 2012. Known under the brand name Blujepa, the drug was approved in the US to treat urinary tract infections in March 2025.

Vaccines

Pharmaceutical Technology

JUNE 25, 2025

June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook BP is a chronic skin disease marked by severe itching, painful blisters, lesions and skin redness. In February 2025, the FDA accepted Dupixent’s supplemental biologics licence application (sBLA) for priority review. Credit: Toa55/Shutterstock.

FDA

Pharmaceutical Technology

JUNE 13, 2025

June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.

Vaccines

Pharmaceutical Technology

JUNE 12, 2025

GlobalData Healthcare June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook European KOLs with cardiomyopathy patients told GlobalData that they are waiting for vutrisiran’s launch for ATTR-wt. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JULY 30, 2025

July 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook MP1032 is intended for treating Duchenne muscular dystrophy. Credit: luchschenF/Shutterstock.com. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Login Registration is disabled.

Packaging

Pharmaceutical Technology

AUGUST 11, 2025

August 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The NDA submission was based on results from the VERITAC-2 clinical trial. Credit: Gorodenkoff/Shutterstock.com. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

FDA

Pharmaceutical Technology

AUGUST 12, 2025

August 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook XH-S004 is being studied for its efficacy against non-cystic fibrosis bronchiectasis in Phase II trials and COPD in Phase Ib trials. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Packaging

Pharmaceutical Technology

JUNE 19, 2025

GlobalData Healthcare June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The oligonucleotide market is well-positioned to drive the next wave of personalised treatment. billion from 2021 to 2025 year-to-date. Credit: Kateryna Kon via Shutterstock. ASOs accounted for more than half ($3.54

Communication

Pharmaceutical Technology

JUNE 6, 2025

June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will support clinical milestones along with AI-driven development across Juvenescence’s portfolio. The acquisition forms a key part of Juvenescence’s partnership with the Abu Dhabi global healthcare company M42, which was announced in April 2025.

Communication

Pharmaceutical Technology

JULY 28, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? GlobalData Healthcare July 28, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Credit: Vitalii Vodolazskyi / Shutterstock.com. Give your business an edge with our leading industry insights.

Packaging

Pharmaceutical Technology

JUNE 10, 2025

June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will be used to advance Mosanna’s nasal spray for obstructive sleep apnoea. Credit: Pixel-Shot/Shutterstock. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JUNE 6, 2025

June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The authorisation in the EU signifies a step forward in eye care for paediatric patients. Credit: chaponta/Shutterstock. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JULY 29, 2025

Abigail Beaney July 29, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The JAK1 inhibitor is already approved in RA and UC. Galapagos contributed around €40m to Alfasigma by June 2025 for Jyseleca development. Image credit: 3dMediSphere / Shutterstock.com. Sign up for our daily news round-up!

Packaging

Pharmaceutical Technology

JULY 30, 2025

A first-in-human Phase I study involving patients with relapsed or refractory B-cell lymphoma is expected to commence using AVC-203 in the second half of 2025. We may still continue to send you service-related and other non-promotional communications. Credit: PanuShot/Shutterstock.com. Sign up for our daily news round-up!

Communication

Pharmaceutical Technology

JULY 21, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? July 21, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The acquisition of Blueprint provides Sanofi with a well-established foothold among allergists, dermatologists and immunologists.

Packaging

Pharmaceutical Technology

JUNE 20, 2025

June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The MoU was signed at the BIO International Convention 2025 in Boston, US. The MoU was signed at the BIO International Convention 2025 in Boston, in the US state of Massachusetts. Credit: Department of Health Abu Dhabi.

Vaccines

Pharmaceutical Technology

JUNE 23, 2025

June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook argenx is collaborating with regional regulatory authorities to facilitate patient access to the treatment. Credit: Wirestock Creators/Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.

Communication

Pharmaceutical Technology

JULY 22, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? In July 2025, J&J submitted a request to the European Medicines Agency (EMA) to expand the indications for Akeega (a combination of niraparib and abiraterone acetate) in the treatment of prostate cancer.

FDA

Pharmaceutical Technology

JULY 21, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? July 21, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Fangzhou and Novo Nordisk have signed a collaboration memorandum. Credit: Fangzhou Inc./GlobeNewswire. GlobeNewswire.

Packaging

Pharmaceutical Technology

JUNE 18, 2025

June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Orion will obtain access to Glykos’ ADC technologies for probable expansion into three new programmes. Credit: Premreuthai/Shutterstock. Sign up for our daily news round-up! Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JUNE 10, 2025

June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Enflonsia is administered to infants with the same dose regardless of their bodyweight. Credit: MargJohnsonVA/Shutterstock. “We Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

FDA

Pharmaceutical Technology

JUNE 17, 2025

Abigail Beaney June 17, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook With potential tariffs and other changes in the US market, it is important for European companies to show they have a scalable model if they want to break into the market. Give your business an edge with our leading industry insights.

Communication

Hospital Pharmacy Europe

APRIL 14, 2025

However, issues arose due to a lack of PAAP, insufficient communication between or within services and families, failure to recognise child deterioration, and treatment delays. Learnings from the CDOPs showed that allergy symptoms were not always communicated to healthcare professionals. Accessed March 2025]. Childhood asthma.

Health and Personal Care Stores

Pharmaceutical Technology

JULY 24, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? July 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Updates in the ICH E6 (R3) guidelines refine the ways clinical trials are designed and operated. Credit: via Shutterstock.

Communication

The Nontraditional Pharmacist

JULY 1, 2025

It’s 2025. Sometimes we exclude medications from our protocol, various CYP enzymes and kind of going through a package insert to see, should we exclude this drug or not? So, good talking to you. Matt Paterini (01:21): No, we appreciate the time. And remember, COVID was in there too, right? So, we would have spoken in 2019.

FDA

Pharmaceutical Technology

JULY 29, 2025

July 29, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The therapy is administered subcutaneously once a week, ensuring a sustained release of active, unmodified somatropin. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

FDA

The FDA Law Blog

JULY 10, 2025

Butler — In a move FDA is calling “radical transparency,” the Agency announced on July 10, 2025 that it has published 200+ Complete Response Letters (CRLs) issued in response to marketing applications for drugs and biologics on its openFDA database. By Sarah Wicks & Michelle L.

FDA

Pharmaceutical Technology

JUNE 23, 2025

June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook HBM7020 activates immune system T cells to target and destroy B cells and plasma cells involved in many autoimmune diseases. We may still continue to send you service-related and other non-promotional communications. Sign up for our daily news round-up!

Communication

Pharmacy Times

JULY 7, 2025

We are communicating this information now to allow time for patients to work closely with their health care teams to develop alternative treatment plans.” 1,3 According to the package insert for Gammagard Liquid ERC, it is contraindicated in patients with severe systemic hypersensitivity or anaphylactic reactions to the product.

FDA

Pharmaceutical Technology

JUNE 26, 2025

June 26, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Regulus becomes Novartis’ indirect wholly owned subsidiary. Find out more The development follows an agreement in April 2025 in which Novartis signed an agreement to acquire Regulus and its oligonucleotide therapy, farabursen. Credit: JHVEPhoto/Shutterstock.

Packaging

Pharmaceutical Technology

JULY 31, 2025

July 31, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Back (from left to right): Cyrille Kuhn (Allianthera), Monika Fritz (Dr Falk Pharma), Dirk Brehmer (Dr Falk Pharma), Xianghong Shao (Allianthera) and Helle Størum (Dr Falk Pharma). Give your business an edge with our leading industry insights.

Packaging

Pharmaceutical Technology

AUGUST 12, 2025

August 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The companies will work together using the NanoSpark tech to develop novel products to meet demands within the fast-growing cell and gene therapy markets. We may still continue to send you service-related and other non-promotional communications.

Immunization

Pharmaceutical Technology

JULY 25, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? July 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The EU approval was supported by efficacy results from the pivotal DREAMM-7 and DREAMM-8 trials.

Packaging

Pharmaceutical Technology

JULY 23, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? July 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The focus of the investment is a manufacturing facility dedicated to producing drug substances for AstraZeneca.

Packaging

Pharmaceutical Technology

JULY 1, 2025

Frankie Fattorini July 1, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The EU Pharma Package’s attempt to balance priorities risks achieving none. Data protection reduction contentious One of the major revisions of the EU Pharma Package is to decrease the period of exclusivity offered to drug developers.

Packaging

Pharmacy Times

JULY 15, 2025

What we've done is blend PillPack's innovative packaging with Amazon Pharmacy's user-friendly approach and affordability, so these patients can now get their medications in convenient, personalized packets and order everything online through our digital pharmacy.

Compounding Pharmacies